InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod

/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new formulation patent for the drug candidate cobitolimod has been granted by...

Related Keywords

Sweden ,Stockholm ,Johan Gil ,Jenny Sundqvist ,Prnewswire Index Pharmaceuticals Holding ,Kindex Pharmaceuticals ,Index Pharmaceuticals Holding ,European Patent Office ,European Patent ,Dex Pharmaceuticals ,Abuse Regulation ,Immunomodulatory Sequences ,Nasdaq First North Growth Market ,Addex Pharma ,